Evidence map›Paper›PMID 35517784›Full record

ArticleFrontiers in pharmacology2022

Rhynchophylline Regulates Calcium Homeostasis by Antagonizing Ryanodine Receptor 2 Phosphorylation to Improve Diabetic Cardiomyopathy.

Jiao Liu, Yating Zhao, Yufang Zhu, Yan Wang, Xiaoshuang Liu, Xiaobo Nie, Jing Zhao, Wei Wang, Jie Cheng

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Post-translational modifications in diabetic cardiomyopathy.Journal of cellular and molecular medicine · 2024
    Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jiao LiuCollege of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Yating ZhaoCollege of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Yufang ZhuCollege of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Yan WangCollege of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Xiaoshuang LiuCollege of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Xiaobo NieCollege of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Jing ZhaoCollege of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, China.
Wei WangCollege of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Jie ChengCollege of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Hebei University of Chinese Medicine · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic cardiomyopathy (DCM) is a serious complication of diabetes that can lead to heart failure and death, for which there is no effective treatment. Rhynchophylline (Rhy) is the main effective component of the Chinese herbal medicine

Indexed as

calcium homeostasismitochondriamyocardial lesionsrhynchophyllinetype 2 diabetes mellitus

Identifiers

PMID35517784
PMCPMC9063879
OpenAlexW4224302575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.